Evidence map›Paper›PMID 9614181›Full record

ArticleMolecular biology of the cell1998

RhoG GTPase controls a pathway that independently activates Rac1 and Cdc42Hs.

C Gauthier-Rouvière, E Vignal, M Mériane, P Roux, P Montcourier, P Fort

Open access · greenAbstract read
In one paragraph

Article in Molecular biology of the cell, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 160 citations in OpenAlex.

  1. Article
  2. Article
  3. Role of RhoG as a regulator of cellular functions: integrating insights on immune cell activation, migration, and functions.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2023
    Review
  4. RhoG's Role in T Cell Activation and Function.Frontiers in immunology · 2022
    Review
  5. Review
  6. Role of RhoC in cancer cell migration.Cancer cell international · 2021
    Review
  7. Progress in the therapeutic inhibition of Cdc42 signalling.Biochemical Society transactions · 2021
    Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

C Gauthier-RouvièreIGMM, CNRS-UMR5535, Route de Mende, 34293 Montpellier Cedex 05 France. gauthier@igm.cnrs-mop.fr
E Vignal
M Mériane
P Roux
P Montcourier
P Fort
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

RhoG is a member of the Rho family of GTPases that shares 72% and 62% sequence identity with Rac1 and Cdc42Hs, respectively. We have expressed mutant RhoG proteins fused to the green fluorescent protein and analyzed subsequent changes in cell surface morphology and modifications of cytoskeletal structures. In rat and mouse fibroblasts, green fluorescent protein chimera and endogenous RhoG proteins colocalize according to a tubular cytoplasmic pattern, with perinuclear accumulation and local concentration at the plasma membrane. Constitutively active RhoG proteins produce morphological and cytoskeletal changes similar to those elicited by a simultaneous activation of Rac1 and Cdc42Hs, i.e., the formation of ruffles, lamellipodia, filopodia, and partial loss of stress fibers. In addition, RhoG and Cdc42Hs promote the formation of microvilli at the cell apical membrane. RhoG-dependent events are not mediated through a direct interaction with Rac1 and Cdc42Hs targets such as PAK-1, POR1, or WASP proteins but require endogenous Rac1 and Cdc42Hs activities: coexpression of a dominant negative Rac1 impairs membrane ruffling and lamellipodia but not filopodia or microvilli formation. Conversely, coexpression of a dominant negative Cdc42Hs only blocks microvilli and filopodia, but not membrane ruffling and lamellipodia. Microtubule depolymerization upon nocodazole treatment leads to a loss of RhoG protein from the cell periphery associated with a reversal of the RhoG phenotype, whereas PDGF or bradykinin stimulation of nocodazole-treated cells could still promote Rac1- and Cdc42Hs-dependent cytoskeletal reorganization. Therefore, our data demonstrate that RhoG controls a pathway that requires the microtubule network and activates Rac1 and Cdc42Hs independently of their growth factor signaling pathways.

Indexed as

3T3 CellsActinsAnimalsBradykinincdc42 GTP-Binding ProteinCell Cycle ProteinsCell LineCytoskeletonGreen Fluorescent ProteinsGTP-Binding ProteinsGTP PhosphohydrolasesLuminescent ProteinsMiceMicrotubulesPlatelet-Derived Growth Factorrac GTP-Binding ProteinsActinsBradykinincdc42 GTP-Binding ProteinCell Cycle ProteinsGreen Fluorescent ProteinsGTP-Binding ProteinsGTP PhosphohydrolasesLuminescent ProteinsPlatelet-Derived Growth Factorrac GTP-Binding ProteinsRecombinant Fusion ProteinsRhog protein, mouseRhog protein, ratrho GTP-Binding ProteinsTranscription Factors

Identifiers

PMID9614181
PMCPMC25357
OpenAlexW2138533227

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.